These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 493022

  • 1. [Progress in the knowledge of complement. I. Structure, activation and control of the complement system].
    Lesavre P, Leibowitch J.
    Nouv Presse Med; 1979 Jun 30; 8(29):2385-7. PubMed ID: 493022
    [No Abstract] [Full Text] [Related]

  • 2. [Complement: mechanisms of activation, functions, analysis].
    Dessaint JP, Wattre P, Santoro F, Capron A.
    Lille Med; 1979 Jun 30; 24(7):551-8. PubMed ID: 397392
    [No Abstract] [Full Text] [Related]

  • 3. [Proteases in complement system (author's transl)].
    Nagasawa S.
    Tanpakushitsu Kakusan Koso; 1980 Jun 30; 25(6):531-46. PubMed ID: 7010425
    [No Abstract] [Full Text] [Related]

  • 4. [Progress in the immunochemical studies of complement--including the establishment of nomenclature of complement proteins].
    Inai S.
    Nihon Rinsho; 1979 May 10; 37(5):923-9. PubMed ID: 381722
    [No Abstract] [Full Text] [Related]

  • 5. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T, Takata Y, Kozono H, Takeda J, Hong KS, Inoue K.
    J Immunol; 1988 Dec 01; 141(11):3895-901. PubMed ID: 3183384
    [Abstract] [Full Text] [Related]

  • 6. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 7. Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.
    Fearon DT, Austen KF.
    N Engl J Med; 1980 Jul 31; 303(5):259-63. PubMed ID: 6900901
    [No Abstract] [Full Text] [Related]

  • 8. [Protein chemistry of the complement system].
    Nagasawa S.
    Tanpakushitsu Kakusan Koso; 1983 Jan 31; 28(1):18-44. PubMed ID: 6340167
    [No Abstract] [Full Text] [Related]

  • 9. [Non-specific immune mechanisms. The alternate pathway in the complement system].
    Schön K, Koeppe HW.
    Med Klin; 1979 Mar 30; 74(13):461-9. PubMed ID: 431472
    [No Abstract] [Full Text] [Related]

  • 10. The biological role of the complement system and the clinical importance of complement measurements.
    Füst G.
    Haematologia (Budap); 1979 Mar 30; 12(1-4):85-106. PubMed ID: 395046
    [Abstract] [Full Text] [Related]

  • 11. The role of immunoglobulins in alternative pathway activation by zymosan. II. The effect of IgG on the kinetics of the alternative pathway.
    Schenkein HA, Ruddy S.
    J Immunol; 1981 Jan 30; 126(1):11-5. PubMed ID: 6905857
    [No Abstract] [Full Text] [Related]

  • 12. Erythrocyte-bound complement components in health and disease.
    Garratty G.
    Prog Clin Biol Res; 1980 Jan 30; 43():133-55. PubMed ID: 6999500
    [No Abstract] [Full Text] [Related]

  • 13. [Recent trends in complement research].
    Inai S.
    Nihon Rinsho; 1983 Jan 30; 41(4):750-5. PubMed ID: 6350645
    [No Abstract] [Full Text] [Related]

  • 14. Activation of the alternative complement pathway.
    Fearon DT.
    CRC Crit Rev Immunol; 1979 Nov 30; 1(1):1-32. PubMed ID: 162484
    [No Abstract] [Full Text] [Related]

  • 15. Activation of the classical complement pathway by nephritic factor bound to the alternative pathway C3/C5 convertase.
    Sobel AT, Cooper NR, Schreiber RD.
    J Immunol; 1979 Jan 30; 122(1):34-8. PubMed ID: 762421
    [Abstract] [Full Text] [Related]

  • 16. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b.
    Pangburn MK, Morrison DC, Schreiber RD, Müller-Eberhard HJ.
    J Immunol; 1980 Feb 30; 124(2):977-82. PubMed ID: 7356723
    [No Abstract] [Full Text] [Related]

  • 17. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S, Tamura N, Fujita T.
    Immunology; 1989 Dec 30; 68(4):449-52. PubMed ID: 2481642
    [Abstract] [Full Text] [Related]

  • 18. Antibody restores human alternative complement pathway activation by mouse erythrocytes rendered functionally deficient by pretreatment with pronase.
    Moore FD, Austen KF, Fearon DT.
    J Immunol; 1982 Mar 30; 128(3):1302-6. PubMed ID: 6915957
    [Abstract] [Full Text] [Related]

  • 19. [Progress in the knowledge of complement. II. Nephritic factors].
    Leibowitch J, Lesavre P.
    Nouv Presse Med; 1979 Jul 07; 8(30):2447-8. PubMed ID: 493036
    [No Abstract] [Full Text] [Related]

  • 20. IgG on mouse erythrocytes augments activation of the human alternative complement pathway by enhancing deposition of C3b.
    Moore FD, Fearon DT, Austen KF.
    J Immunol; 1981 May 07; 126(5):1805-9. PubMed ID: 6908606
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.